| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DEMANT.CO - | BUY | 10,228 @ DKK 29.1095 | DKK 297,732 | The ETF bought 10228 new shares of DEMANT.CO (). The shares were bought for an average price of 29.1095 compared to the previous average buy price of 33.8297. This is -14.0% lower than average price of previous purchases of DEMANT.CO. |
| ARGX.BR - Argenx SE | BUY | 218 @ EUR 785.6 | EUR 171,261 | The ETF bought 218 new shares of ARGX.BR (Argenx SE). The shares were bought for an average price of 785.6 compared to the previous average buy price of 577.371. This is 36.1% higher than average price of previous purchases of ARGX.BR. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 127.6 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 127.6. The average price that IPN.PA shares were previous bought at was EUR 110.236. The current market price is 15.8% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 17,837 (USD $20,526) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 236.1 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 236.1. The average price that UCB.BR shares were previous bought at was EUR 188.64. The current market price is 25.2% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 370,518 (USD $426,378) compared to the previous valuation of UCB SA however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 112.8 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 112.8. The average price that MRK.DE shares were previous bought at was EUR 117.741. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 61,162 (USD $70,383) compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 60.1 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 60.1. The average price that ORNBV.HE shares were previous bought at was EUR 59.6415. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 15,453 (USD $17,783) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 23.79 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 23.79. The average price that PHIA.AS shares were previous bought at was EUR 22.3184. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 218,449 (USD $251,383) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 41.055 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 41.055. The average price that QIA.DE shares were previous bought at was EUR 39.6. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in QIA.DE has increased by EUR 138,323 (USD $159,177) compared to the previous valuation of QIAGEN NV however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 50.1 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 50.1. The average price that REC.MI shares were previous bought at was EUR 52.8051. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 70,665 (USD $81,319) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| RO.SW - | HOLD | 0 @ CHF 344.917 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 344.917. The average price that RO.SW shares were previous bought at was CHF 303.069. The current market price is 13.8% higher than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 175,555 (USD $217,091) compared to the previous valuation of |
| SDZ.SW - | HOLD | 0 @ CHF 59.7055 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 59.7055. The average price that SDZ.SW shares were previous bought at was CHF 46.5488. The current market price is 28.3% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 335,752 (USD $415,190) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 42.18 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 42.18. The average price that SHL.DE shares were previous bought at was EUR 47.3083. The current market price is -10.8% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 131,232 (USD $151,017) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 30.553 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 30.553. The average price that SOBI.ST shares were previous bought at was SEK 26.6803. The current market price is 14.5% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 53,964 (USD $5,657) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 211.117 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 211.117. The average price that SOON.SW shares were previous bought at was CHF 261.734. The current market price is -19.3% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 74,732 (USD $92,413) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 231.5 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 231.5. The average price that SRT3.DE shares were previous bought at was EUR 216.243. The current market price is 7.1% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 154,027 (USD $177,248) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 105.988 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 105.988. The average price that STMN.SW shares were previous bought at was CHF 110.167. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 225,977 (USD $279,443) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 66.127 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 66.127. The average price that ALC.SW shares were previous bought at was CHF 74.0197. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 11,533 (USD $14,262) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 18.2782 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 18.2782. The average price that HIK.L shares were previous bought at was GBP 22.4918. The current market price is -18.7% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 20,680 (USD $27,083) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 30.595 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 30.595. The average price that BAYN.DE shares were previous bought at was EUR 25.3269. The current market price is 20.8% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 2,795,378 (USD $3,216,813) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 108.7 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 108.7. The average price that BIM.PA shares were previous bought at was EUR 114.368. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 38,878 (USD $44,739) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 77.5272 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 77.5272. The average price that COLO-B.CO shares were previous bought at was DKK 83.3687. The current market price is -7.0% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 18,511 (USD $2,852) compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 194.55 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 194.55. The average price that DIM.PA shares were previous bought at was EUR 192.588. The current market price is 1.0% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 126,049 (USD $145,052) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 58.5 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 58.5. The average price that ERF.PA shares were previous bought at was EUR 57.6176. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 80,300 (USD $92,406) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 41.4 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 41.4. The average price that FME.DE shares were previous bought at was EUR 46.1012. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 179,385 (USD $206,429) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 47.2 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 47.2. The average price that FRE.DE shares were previous bought at was EUR 42.5611. The current market price is 10.9% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 103,840 (USD $119,495) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 160.754 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 160.754. The average price that GALD.SW shares were previous bought at was CHF 131.712. The current market price is 22.0% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 284,673 (USD $352,026) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 268.6 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 268.6. The average price that GMAB.CO shares were previous bought at was DKK 207.412. The current market price is 29.5% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 293,812 (USD $45,275) compared to the previous valuation of however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.3 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.3. The average price that GRF.MC shares were previous bought at was EUR 10.681. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 43,479 (USD $50,034) compared to the previous valuation of Grifols SA however if the holding was sold on 2025-11-24 this would crystalise an overall loss. |
| LONN.SW - | SELL | -151 @ CHF 574.289 | CHF -86,718 | The ETF sold 151 shares of LONN.SW on 2025-11-24. The shares were previously bought for an average price of CHF 603.974. The shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 4,482 (USD $5,543) The average price that the ETF previously sold LONN.SW share for is CHF 586.847 which is higher than the selling price of CHF 574.289 on 2025-11-24. |
| EL.PA - EssilorLuxottica SA | SELL | -624 @ EUR 303.7 | EUR -189,509 | The ETF sold 624 shares of EL.PA on 2025-11-24. The shares were previously bought for an average price of EUR 262.019. The EssilorLuxottica SA shares were sold for 15.9% higher than average price of previous purchases. This sale made a profit of EUR 26,009 (USD $29,930) The average price that the ETF previously sold EL.PA share for is EUR 255.486 so the ETF has sold 624 shares on 2025-11-24 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -2,536 @ EUR 85.95 | EUR -217,969 | The ETF sold 2536 shares of SAN.PA on 2025-11-24. The shares were previously bought for an average price of EUR 87.0732. The Sanofi SA shares were sold for -1.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,848 (USD $3,278) The average price that the ETF previously sold SAN.PA share for is EUR 92.571 which is higher than the selling price of EUR 85.95 on 2025-11-24. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -6,655 @ DKK 38.4288 | DKK -255,744 | The ETF sold 6655 shares of NOVO-B.CO on 2025-11-24. The shares were previously bought for an average price of DKK 54.6547. The Novo Nordisk A/S shares were sold for -29.7% lower than average price of previous purchases. This resulted in an overall loss of DKK 107,983 (USD $16,640) The average price that the ETF previously sold NOVO-B.CO share for is DKK 57.5304 which is higher than the selling price of DKK 38.4288 on 2025-11-24. |
| HLN.L - Haleon PLC | SELL | -92,398 @ GBP 4.22364 | GBP -390,256 | The ETF sold 92398 shares of HLN.L on 2025-11-24. The shares were previously bought for an average price of GBP 4.40407. The Haleon PLC shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of GBP 16,671 (USD $21,833) The average price that the ETF previously sold HLN.L share for is GBP 4.60965 which is higher than the selling price of GBP 4.22364 on 2025-11-24. |
| SN.L - Smith & Nephew PLC | SELL | -27,708 @ GBP 14.2681 | GBP -395,341 | The ETF sold 27708 shares of SN.L on 2025-11-24. The shares were previously bought for an average price of GBP 13.6826. The Smith & Nephew PLC shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of GBP 16,223 (USD $21,249) The average price that the ETF previously sold SN.L share for is GBP 12.8302 so the ETF has sold 27708 shares on 2025-11-24 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -3,945 @ CHF 110.605 | CHF -436,337 | The ETF sold 3945 shares of NOVN.SW on 2025-11-24. The shares were previously bought for an average price of CHF 104.068. The shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of CHF 25,788 (USD $31,894) The average price that the ETF previously sold NOVN.SW share for is CHF 100.083 so the ETF has sold 3945 shares on 2025-11-24 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -1,438 @ CHF 333.857 | CHF -480,086 | The ETF sold 1438 shares of ROG.SW on 2025-11-24. The shares were previously bought for an average price of CHF 287.784. The shares were sold for 16.0% higher than average price of previous purchases. This sale made a profit of CHF 66,253 (USD $81,928) The average price that the ETF previously sold ROG.SW share for is CHF 279.876 so the ETF has sold 1438 shares on 2025-11-24 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -3,173 @ GBP 158.29 | GBP -502,254 | The ETF sold 3173 shares of AZN.L on 2025-11-24. The shares were previously bought for an average price of GBP 131.68. The AstraZeneca PLC shares were sold for 20.2% higher than average price of previous purchases. This sale made a profit of GBP 84,434 (USD $110,576) The average price that the ETF previously sold AZN.L share for is GBP 126.995 so the ETF has sold 3173 shares on 2025-11-24 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -26,678 @ GBP 20.3798 | GBP -543,692 | The ETF sold 26678 shares of GSK.L on 2025-11-24. The shares were previously bought for an average price of GBP 17.3382. The GlaxoSmithKline PLC shares were sold for 17.5% higher than average price of previous purchases. This sale made a profit of GBP 81,144 (USD $106,268) The average price that the ETF previously sold GSK.L share for is GBP 16.7117 so the ETF has sold 26678 shares on 2025-11-24 at a higher price than the previous selling average. |